Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of share options

17 Oct 2017 09:10

RNS Number : 7995T
Touchstone Innovations PLC
17 October 2017
 

17 October 2017

 

Touchstone Innovations plc

 

Grant of share options

 

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation. 

 

Touchstone Innovations plc (AIM: IVO, "Innovations" or "the Group") has today granted options over ordinary shares in the capital of the Group ("Award Shares") to the following PDMRs under its 2016 Long Term Incentive Plan ("LTIP").

 

Number of Award Shares

Russ Cummings

315,515

Nigel Pitchford

94,827

Tony Hickson

55,173

Anjum Ahmad

46,433

 

The options have an exercise price of 3 1/33 (three and one thirty-third) pence per Award Share and are exercisable in three equal tranches during the six month periods commencing on 1 December 2020, 1 December 2021 and 1 December 2022 respectively, subject to certain performance conditions having been satisfied.

 

This grant of options is part of the Company's long-term incentive arrangements designed to align the interests of the shareholders and executives.

 

The LTIP was approved by shareholders of the Company at an annual general meeting on 21 November 2016 and was adopted by the Board on the same day. The LTIP provides for options to acquire ordinary shares to be granted to eligible employees. The arrangements are described more fully in the Directors' Remuneration Report in the Group's 2016 Annual Report, a copy of which is available on the Group's website (www.touchstoneinnovations.com).

 

For further information please contact:

 

Touchstone Innovations plc

020 3053 8834

David Newlands, Chairman

William Rayner, Company Secretary

 

Instinctif Partners

020 7457 2020

Adrian Duffield/Melanie Toyne-Sewell/Chantal Woolcock

 

J.P. Morgan Cazenove (Nominated Adviser)

020 7742 4000

Michael Wentworth-Stanley/Alec Pratt

 

RBC Capital Markets

020 7653 4000

Darrell Uden/Marcus Jackson/Laura White

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Russ Cummings

 

2.

Reason for the notification

a)

Position / status

CHIEF EXECUTIVE OFFICER

b)

Initial notification/amendment

INITIAL NOTIFICATION

3.

Details of issuer

a)

Name

touchstone Innovations plc

b)

LEI

213800D4RUIF3HLITE31

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

NOMINAL VALUE OPTIONS OVER ORDINARY SHARES OF 3 1/33 PENCE EACH IN THE CAPITAL OF THE COMPANY

GB00B170L953

b)

Nature of the transaction

grant of long term incentive plan awards

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

315,515

d)

Aggregated information

 

Aggregated volume price

N/A

 

e)

Date of the transaction

 

2017-10-17

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

nigel pitchford

2.

Reason for the notification

a)

Position / status

CHIEF INVESTMENT OFFICER

b)

Initial notification/amendment

INITIAL NOTIFICATION

3.

Details of issuer

a)

Name

touchstone Innovations plc

b)

LEI

213800D4RUIF3HLITE31

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

NOMINAL VALUE OPTIONS OVER ORDINARY SHARES OF 3 1/33 PENCE EACH IN THE CAPITAL OF THE COMPANY

GB00B170L953

b)

Nature of the transaction

grant of long term incentive plan awards

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

94,827

d)

Aggregated information

 

Aggregated volume price

N/A

 

e)

Date of the transaction

 

2017-10-17

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

TONY HICKSON

 

2.

Reason for the notification

a)

Position / status

MANAGING DIRECTOR - TECHNOLOGY TRANSFER

b)

Initial notification/amendment

INITIAL NOTIFICATION

3.

Details of issuer

a)

Name

touchstone Innovations plc

b)

LEI

213800D4RUIF3HLITE31

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

NOMINAL VALUE OPTIONS OVER ORDINARY SHARES OF 3 1/33 PENCE EACH IN THE CAPITAL OF THE COMPANY

GB00B170L953

b)

Nature of the transaction

grant of long term incentive plan awards

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

55,173

d)

Aggregated information

 

Aggregated volume price

N/A

 

e)

Date of the transaction

 

2017-10-17

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

ANJUM AHMAD

 

2.

Reason for the notification

a)

Position / status

TREASURY AND FINANCE DIRECTOR

b)

Initial notification/amendment

INITIAL NOTIFICATION

3.

Details of issuer

a)

Name

touchstone Innovations plc

b)

LEI

213800D4RUIF3HLITE31

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

NOMINAL VALUE OPTIONS OVER ORDINARY SHARES OF 3 1/33 PENCE EACH IN THE CAPITAL OF THE COMPANY

GB00B170L953

b)

Nature of the transaction

grant of long term incentive plan awards

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

46,433

d)

Aggregated information

 

Aggregated volume price

N/A

 

e)

Date of the transaction

 

2017-10-17

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEAPEXFENXFEF
Date   Source Headline
12th Dec 20123:02 pmRNSResult of AGM
16th Nov 20127:00 amRNSVeryan CE Mark approval for BioMimics 3D Stent
5th Nov 20127:00 amRNSPortfolio companies receive government funding
19th Oct 201210:00 amRNSGrant of share options
5th Oct 20127:00 amRNSFull year results
4th Oct 20127:00 amRNSCircassia initiates phase III trial
26th Sep 20127:00 amRNSPsiOxus commences clinical trial
20th Sep 201212:39 pmRNSNotice of Results
13th Sep 20123:25 pmRNSCircassia appoints Dr Brett Haumann as CMO
12th Sep 201211:35 amRNSAward Win
6th Sep 20127:00 amRNSInvestment in Cambridge technology company
1st Aug 20123:58 pmRNSDirector Dealings
23rd Jul 20127:00 amRNSInvestment in portfolio company
11th Jul 20122:50 pmRNSVeryan Medical appoints new COO and NEDs
9th Jul 20127:00 amRNS£22m funding round for PsiOxus Therapeutics
5th Jul 20125:20 pmRNSGrant of share options
27th Jun 20128:12 amRNSAbingdon Health acquires controlling stake
18th Jun 20127:00 amRNSInvestment in Oxford healthcare company
12th Jun 20127:00 amRNSInvestment in Cambridge technology company
31st May 20129:36 amRNSDirector/PDMR Shareholding
29th May 201210:05 amRNSPolytherics expands relationship with Pro Bono Bio
24th May 20127:00 amRNSDirector Dealings
1st May 20123:04 pmRNSDirector Dealings
23rd Apr 20127:00 amRNSHalf year results
26th Mar 20123:51 pmRNSNotice of Results
26th Mar 20127:00 amRNSInvestment in portfolio company
21st Mar 20127:00 amRNSDirectorate Change
8th Mar 20127:00 amRNSCircassia Phase II Clinical Trial Success
13th Feb 20127:00 amRNSInvestment in portfolio company
14th Dec 20115:27 pmRNSResult of AGM
6th Dec 20117:00 amRNSInvestment in new start-up
5th Oct 20117:00 amRNSFinal Results
27th Sep 20118:56 amRNSNotice of Results
7th Sep 20117:00 amRNSFurther investment in portfolio company
25th Aug 20117:00 amRNSInvestment in Cambridge company
22nd Aug 20117:00 amRNSInvestment in new company
3rd Aug 20117:00 amRNSInvestment in portfolio company
20th Jul 20117:00 amRNSInvestment in Stanmore
22nd Jun 20119:35 amRNSPortfolio company joint venture
19th Apr 20117:00 amRNSCircassia raises £60m
19th Apr 20117:00 amRNSHalf Yearly Report
30th Mar 201112:41 pmRNSNotice of Results
7th Feb 20116:00 pmRNSNotification of major interest in shares
3rd Feb 20118:16 amRNSDirectors' Dealings
27th Jan 20112:56 pmRNSNotification of major interest in shares
27th Jan 20112:51 pmRNSNotification of major interest in shares
26th Jan 20116:01 pmRNSNotification of major interest in shares
25th Jan 20116:03 pmRNSDirectors' Dealings
25th Jan 20115:40 pmRNSResults of Rump placing
24th Jan 20114:11 pmRNSVoting rights & share capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.